View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Trastuzumab Deruxtecan 5.4, Breast Cancer
Protocol-ID: 1634 V1.0 (Mini), TRASDE5.4, Breast CaIndication(s)
- Breast Cancer (HER2+, HER2-low); ICD-10 C50.-
Links
- Trastuzumab-Deruxtecan (enhertu) [EMA EPAR]
- ENHERTU (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 10.09.2020